Manufacturing

Articles

Yposkesi is building its second commercial facility for cell and gene therapy manufacturing at its campus on Corbeil-Essonnes, France.

Yposkesi Launches Project SKY for its Second Commercial Bioproduction Site

Optima has teamed up with the Robert-Bosch-Krankenhaus and Heidelberg University to develop a unit for decentralized, automated production of CAR-T cell therapies.

Optima Teams Up with Clinics to Develop Production Unit for CAR-T Cell Therapies

VIVEbiotech has opened its new lentiviral vector manufacturing facilities in Spain, expanding capacity for lentiviral vectors for use in cell and gene therapies.

VIVEbiotech Launches Lentiviral Vector Manufacturing Plant for Cell and Gene Therapies

Feliza Mirasol is the science editor for 

The emergence of new biotherapeutics is both the driver and result of innovative drug development technologies.

New Biotherapies Push Technological Innovation Forward

Jennifer Markarian is manufacturing editor of Pharmaceutical Technology.

Process intensification in continuous biopharmaceutical processing can change the way the equipment is used and thus affect cleaning methods.

Considerations for Cleaning Biopharmaceutical Process Equipment

Editor of Pharmaceutical Technology Europe

Certain therapeutics, such as ophthalmics, must be provided as a sterile dosage form but can pose fill/finish challenges due to the small batch sizes required and the fact that the products used are difficult to fill and of high value.

Eyeing Up Success in Fill/Finish

The latest news about biologics facilities includes various expansions, new locations, and acquisitions in the bio/pharmaceutical space. 

Biologics Facilities Expand and Establish New  Locations in 2021

Lonza plans to invest approximately CHF 850 million (US$936 million) to build new state-of-the-art mammalian manufacturing facilities at its Visp, Switzerland, and Portsmouth, NH, sites.

Lonza to Expand Sites with Next-Generation Mammalian Manufacturing Facilities

Avantor plans to increase its single-use manufacturing footprint by 30% and double its cleanroom space in the US and Europe.

Avantor to Increase Global Capacity for Single-Use Technologies

AkesoBio’s expanded manufacturing capacity, enabled by the addition of another Cytiva FlexFactory platform, will be used to meet current and future market needs in China as well as worldwide.

Manufacturing Equipment, Biologics